semaglutide lowers risk of heart issues regardless of weight loss Cuts Beyond Loss: Study Ozempic Research Shows Cardiovascular Benefits
Description
Each Wegovy pen contains Semaglutide 0.5 mg per dose
80 4 mg 19.0% weight loss 9 mg 25.9% weight loss 12 mg 28.3% weight loss Placebo 2.2% 45.3% of participants on the highest dose lost 30% of their body weight a threshold historically associated with bariatric surgery
Learn how GLP-1 can help
Ozempic was designed for adults with type 2 diabetes, however researchers begin studying it as a possible method for treating drug addiction.
Achieve lasting results with actionable data.
endometrial cancer
